Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Asseburg · SciRah

Researcher profile · Semantic Scholar

C. Asseburg

Share profile

C. Asseburg — researcher profile on SciRah

h-index: 21
Works: 71
Citations: 1,488

Most-cited papers

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
S. King, S. Griffin, Z. Hodges, H. Weatherly +6 more
2006Health Technology Assessment185 citations Open access
Semantic Scholar
The Functional Response of a Generalist Predator
S. Smout, C. Asseburg, Jason Matthiopoulos, Carmen Fernández +3 more
2010PLoS ONE128 citations Open access
Semantic Scholar
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
N. Woolacott, Y. Vergel, N. Hawkins, A. Kainth +9 more
2006Health Technology Assessment124 citations Open access
Semantic Scholar
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.
T. Colbourn, C. Asseburg, L. Bojke, Zoe Philips +3 more
2007Health Technology Assessment90 citations Open access
Semantic Scholar
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
A. Palmer, L. Si, M. Tew, X. Hua +24 more
2018Value in Health74 citations Open access
Semantic Scholar
Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model
J. Ramsberg, C. Asseburg, M. Henriksson
2012PLoS ONE68 citations Open access
Semantic Scholar
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.
Y. Vergel, N. Hawkins, K. Claxton, C. Asseburg +4 more
2007Rheumatology67 citations
Semantic Scholar
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses
T. Colbourn, C. Asseburg, L. Bojke, Zoë Philips +4 more
2007British medical journal66 citations Open access
Semantic Scholar
Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial
T. Purmonen, Emma Pänkäläinen, J. Turunen, C. Asseburg +1 more
2011Acta oncologica48 citations Open access
Semantic Scholar
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
C. Asseburg, M. Frank, C. Köhne, J. Hartmann +5 more
2011Clinical Therapeutics44 citations
Semantic Scholar
Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
Yolanda Bravo Vergel, S. Palmer, C. Asseburg, E. Fenwick +3 more
2007Heart44 citations Open access
Semantic Scholar
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis
C. Asseburg, Yolanda Bravo Vergel, S. Palmer, E. Fenwick +3 more
2007Heart44 citations Open access
Semantic Scholar
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.
L. Si, M. Willis, C. Asseburg, A. Nilsson +22 more
2020Value in Health39 citations Open access
Semantic Scholar
Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project
A. Wailoo, S. Goodacre, F. Sampson, M. H. Alava +6 more
2009Heart38 citations
Semantic Scholar
Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)
M. Willis, C. Asseburg, Jian-Ming He
2013Journal of Medical Economics37 citations Open access
Semantic Scholar
Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
U. Theidel, C. Asseburg, E. Giannitsis, H. Katus
2013Clinical Research in Cardiology36 citations Open access
Semantic Scholar
Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
M. Willis, P. Johansen, A. Nilsson, C. Asseburg
2017PharmacoEconomics (Auckland)34 citations
Semantic Scholar
Multivariate Prediction Equations for HbA1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling.
M. Willis, C. Asseburg, A. Nilsson, K. Johnsson +1 more
2017Value in Health30 citations Open access
Semantic Scholar
Top Predators in Marine Ecosystems: The functional response of generalist predators and its implications for the monitoring of marine ecosystems
C. Asseburg, J. Harwood, Jason Matthiopoulos, S. Smout
200626 citations
Semantic Scholar
Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data
T. Hallinen, E. Soini, C. Asseburg, Pekka Kuosmanen +1 more
2014BMJ Open24 citations Open access
Semantic Scholar
Cost effectiveness of golimumab for the treatment of active psoriatic arthritis
E. Cummins, C. Asseburg, M. Prasad, J. Buchanan +1 more
2012European Journal of Health Economics23 citations
Semantic Scholar
Cost‐effectiveness of a barrier‐strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden – with model applications for Denmark, Norway and Finland
F. Hjalte, C. Asseburg, G. Tennvall
2010Journal of the European Academy of Dermatology and Venereology20 citations
Semantic Scholar
Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data
M. Willis, C. Asseburg, A. Slee, A. Nilsson +1 more
2020Diabetes Therapy17 citations Open access
Semantic Scholar
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
C. Asseburg, M. Willis, M. Lothgren, N. Seppälä +2 more
2012Schizophrenia Research and Treatment17 citations Open access
Semantic Scholar
Sensitivity to assumptions in models of generalist predation on a cyclic prey.
Jason Matthiopoulos, Kate E. Graham, S. Smout, C. Asseburg +4 more
2007Ecology17 citations
Semantic Scholar
Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review
M. Willis, C. Asseburg, A. Nilsson, C. Neslusan
2019Diabetes Therapy16 citations Open access
Semantic Scholar
Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis.
E. Cummins, C. Asseburg, Y. Punekar, E. Shore +3 more
2011Value in Health16 citations Open access
Semantic Scholar
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
T. Hallinen, E. Soini, C. Asseburg, M. Linna +3 more
2021ClinicoEconomics and Outcomes Research15 citations Open access
Semantic Scholar
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge
M. Tew, M. Willis, C. Asseburg, H. Bennett +29 more
2021Medical decision making12 citations Open access
Semantic Scholar
Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A Meta-Analysis
Dagny Zhu, Suyen Karki, M. Dhariwal, E. Soini +1 more
2024Ophthalmology and Therapy11 citations Open access
Semantic Scholar
The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).
A. Manca, C. Asseburg, Yolanda Bravo Vergel, M. Seymour +4 more
2012Value in Health10 citations
Semantic Scholar
Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland
E. Soini, C. Asseburg, M. Taiha, K. Puolakka +2 more
2017Advances in Therapy9 citations Open access
Semantic Scholar
Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland
A. Puolitaival, M. Savola, Petri Tuomainen, C. Asseburg +2 more
2022Advances in Therapy8 citations Open access
Semantic Scholar
COST-EFFECTIVENESS OF ORAL TRIPTANS FOR ACUTE MIGRAINE: MIXED TREATMENT COMPARISON
C. Asseburg, P. Peura, T. Oksanen, J. Turunen +2 more
2012International Journal of Technology Assessment in Health Care8 citations
Semantic Scholar
Macrovascular Risk Equations Based on the CANVAS Program
M. Willis, C. Asseburg, A. Slee, A. Nilsson +1 more
2021PharmacoEconomics (Auckland)7 citations
Semantic Scholar
Conducting and interpreting results of network meta-analyses in type 2 diabetes mellitus: A review of network meta-analyses that include sodium glucose co-transporter 2 inhibitors.
M. Willis, C. Asseburg, C. Neslusan
2019Diabetes Research and Clinical Practice7 citations
Semantic Scholar
A Bayesian approach to modelling field data on multi-species predator prey-interactions
C. Asseburg
20065 citations
Semantic Scholar
Cost-effectiveness of insulin glargine compared to other long-acting basal insulins in the treatment of Finnish type 1 and type 2 diabetes patients based on individual studies
T. Hallinen, E. Soini, C. Asseburg, R. Suominen +1 more
20124 citations
Semantic Scholar
The Cost-Effectiveness of Primary Angioplasty Compared to Thrombolytic Therapy for Acute Myocardial Infarction in the UK NHS
Y. Vergel, S. Palmer, C. Asseburg, E. Fenwick +3 more
20074 citations
Semantic Scholar
Preventive strategies for group B streptococcal and other bacterial infections in early infancy : cost effectiveness and value of information analyses
T. Colbourn, C. Asseburg, L. Bojke, Zoë Philips +3 more
20073 citations
Semantic Scholar
Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Finland Between 2008 and 2020 (FINPAH) - A Descriptive Real-World Cohort Study
M. Pentikäinen, P. Simonen, H. Tuunanen, P. Leskelä +7 more
2023The Journal of Heart and Lung Transplantation2 citations
Semantic Scholar
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
E. Soini, M. Holmberg, C. Asseburg, M. Sumelahti
2014Value in Health2 citations Open access
Semantic Scholar
CO131 Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients in Finland (FINPAH) – A Descriptive Retrospective Real World Cohort Study Between 2008 and 2020
M. Pentikäinen, E. Soini, C. Asseburg, P. Mankinen +3 more
2022Value in Health1 citations Open access
Semantic Scholar
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
T. Hallinen, E. Soini, C. Asseburg, M. Linna +3 more
20211 citations
Semantic Scholar
Assessing the Value of Canagliflozin (CANA) vs. Sitagliptin (SITA) as Second-Line Therapy in the U.S.—The Importance of Considering Evidence from the CANVAS Program
M. Willis, C. Neslusan, A. Nilsson, C. Asseburg
2018Diabetes1 citations
Semantic Scholar
Cost-Effectiveness Depends on the Subsequent Treatment Sequence: An Example from Multiple Sclerosis
C. Asseburg, J. Svensson, Emelie Andersson, U. Persson +1 more
20161 citations Open access
Semantic Scholar
UPDATE OF THE MODEL VALIDATION OF THE ECONOMIC AND HEALTH OUTCOMES MODEL OF TYPE 2 DIABETES MELLITUS (ECHO-T2DM)
C. Asseburg, M. Willis, P. Johansen, A. Nilsson +2 more
20161 citations Open access
Semantic Scholar
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
E. Soini, C. Asseburg, M. Sumelahti
2014Value in Health1 citations Open access
Semantic Scholar
[Indirect comparison and network meta-analyses--new tools for the assessment of evidence on the relative efficacy of drugs].
P. Peura, C. Asseburg, J. Turunen, T. Purmonen +1 more
2011Duodecim lääketieteellinen aikakauskirja1 citations
Semantic Scholar
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany
U. Theidel, C. Asseburg, E. Giannitsis, H. Katus
20111 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Willis×14
Invite
M. Willis — researcher profile on SciRah
A. Nilsson×9
Invite
A. Nilsson — researcher profile on SciRah
E. Soini×9
Invite
E. Soini — researcher profile on SciRah
M. Sculpher×7
Invite
M. Sculpher — researcher profile on SciRah

×6

Invite

S. Palmer — researcher profile on SciRah

Invite

C. Neslusan — researcher profile on SciRah

Invite

K. Claxton — researcher profile on SciRah

Invite

E. Fenwick — researcher profile on SciRah

Invite

K. Abrams — researcher profile on SciRah

Invite

T. Hallinen — researcher profile on SciRah

Invite

S. Smout — researcher profile on SciRah

Jason Matthiopoulos×3

Invite

Jason Matthiopoulos — researcher profile on SciRah